Erysipelas physical examination

Jump to navigation Jump to search

Erysipelas Microchapters


Patient Information


Historical Perspective




Differentiating Erysipelas from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination


X Ray



Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Erysipelas physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Erysipelas physical examination

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Erysipelas physical examination

CDC on Erysipelas physical examination

Erysipelas physical examination in the news

Blogs on Erysipelas physical examination

Directions to Hospitals Treating Erysipelas

Risk calculators and risk factors for Erysipelas physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S., Kiran Singh, M.D. [2]


Erysipelas manifests with a characteristic rash, localized on the epidermis. Signs include erythema, edema, bullae, vesicles, and blebs. It usually manifests on the legs, but can also be found on the face, torso, hands, feet, and toes. The patient may also be ill-appearing if there is presence of systemic illness, such as fever, chills, or vomiting.

Physical Examination

Appearance of the Patient

The patient may be ill-appearing if systemic illness such as fever, chills, or vomiting is present.[1]

Vital signs

Fever may be present in erysipelas patients.


Erysipelas manifests with a characteristic rash, localized on the epidermis, with the following presentation:[2]


Erysipelas is most commonly found in the leg.[5]

  • Secondarily, it is found on the face, as well as torso, toes, feet, and hands.[6]

Examples of Physical Examination Findings for Erysipelas





  1. {{cite journal |vauthors=Inghammar M, Rasmussen M, Linder A |title=Recurrent erysipelas--risk factors and clinical presentation |journal=BMC Infect. Dis. |volume=14 |issue= |pages=270 |year=2014 |pmid=24884840 |pmc=4033615 |doi=10.1186
  2. Bläckberg A, Trell K, Rasmussen M (2015). "Erysipelas, a large retrospective study of aetiology and clinical presentation". BMC Infect. Dis. 15: 402. doi:10.1186/s12879-015-1134-2. PMC 4590694. PMID 26424182.
  3. Chong FY, Thirumoorthy T (2008). "Blistering erysipelas: not a rare entity". Singapore Med J. 49 (10): 809–13. PMID 18946616.
  4. Ferretti JJ, Stevens DL, Fischetti VA, Stevens DL, Bryant AE. PMID 26866211. Missing or empty |title= (help)
  5. Bernard P, Chosidow O, Vaillant L (2002). "Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial". BMJ. 325 (7369): 864. PMC 129632. PMID 12386036.
  6. Krasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A (2006). "Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance". Dermatology (Basel). 212 (1): 31–5. doi:10.1159/000089019. PMID 16319471.
  7. 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 7.10 7.11 7.12 7.13 7.14 7.15 7.16 7.17 7.18 7.19 7.20 7.21 7.22 7.23 7.24 7.25 7.26 7.27 7.28 7.29 7.30 7.31 7.32 7.33 7.34 7.35 7.36 "Dermatology Atlas".

Template:WH Template:WS